Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355)
Xinyi Liu, Wenbin Shen, Zhimin Zeng(Nanchang University), Yuanji Xu(Cancer Hospital of Chinese Academy of Medical Sciences), Min Hou(Affiliated Hospital of North Sichuan Medical College), Pudong Qian(Jiangsu Cancer Hospital), Chenyu Wang(Anyang Tumor Hospital), Yatian Liu(Jiangsu Cancer Hospital), Yaowen Zhang(Anyang Tumor Hospital), Lulu Wang(Nanjing Drum Tower Hospital), Yaqi Song(Huaian First People’s Hospital), Jingyuan Wen(University of Auckland), Jianzhong Cao(Shanxi Provincial Cancer Hospital), Jiahua Lv(University of Electronic Science and Technology of China), Honglei Luo(Huaian First People’s Hospital), Wei Zhou(Broad Institute), Qing Hou(Shanxi Provincial Cancer Hospital), Yan Gui(First Hospital of Lanzhou University), Xianghua Ye
Cited by 3
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256
Phase separation of OCT4 controls TAD reorganization to promote cell fate transitions
|Cell stem cell|2021|159
Rapidly in Situ Forming Biodegradable Robust Hydrogels by Combining Stereocomplexation and Photopolymerization
|Journal of the American Chemical Society|2007|156
Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases
|Journal of Thoracic Oncology|2016|156